1,25-Dihydroxyvitamin D vs 25-Hydroxyvitamin D in the Athlete Clinical Workup: Why the Active-Form Assay Reads the Calcium-Demand-Driven Up-Regulation the Storage-Form Trajectory Does Not See, the Four Paired-Draw Patterns That Classify the Vitamin D Endocrine Axis, the Four Athlete-Population Presentations That Earn the Ordered Paired Draw, and the SOAP Structure That Carries the Finding Into the Dietary, Bone-Health, and Sports-Endocrinology-Referral Branches of the Plan
A 28-year-old female collegiate cross-country runner at week 11 of a 16-week outdoor track build presents with a four-week plateau on her 5k pace, muscle soreness extending into day three after her hard sessions, a 24-hour recall log at 1,800 kcal against an estimated 2,400 kcal need, a cycle gap at eight weeks, and a 25-hydroxyvitamin D of 42 ng/mL drawn at her annual physical. The storage-form vitamin D reads replete against both the Endocrine Society and Institute of Medicine reference brackets. The clinician reads the panel as vitamin D sufficient. The persistent symptom complex, the cycle disruption, and the low-energy-availability pattern on the log tell the sports RD the vitamin D endocrine axis is not readable from the 25-OH-D alone. The marker that reads the calcium-demand-driven activation of the renal 1-alpha-hydroxylase — 1,25-dihydroxyvitamin D, calcitriol, the active hormonal form — is the one the sports RD pairs with the storage marker on the next draw. This is the paired 25-OH-D plus 1,25-DH-D interpretation guide for the sports RD: the storage-vs-hormone biology that drives the dissociated read, the Endocrine Society and active-form reference brackets, the four paired-draw patterns that classify the vitamin D endocrine axis, the four athlete-population presentations that earn the ordered paired draw, the paired-panel assembly against the calcium-phosphate-PTH-FGF-23 axis, the SOAP structure that carries the finding into the dietary, bone-health, and sports-endocrinology-referral branches of the plan, and the eight-to-twelve-week follow-on redraw cadence that tracks the recovery trajectory against the pattern-specific intervention.
A 28-year-old female collegiate cross-country runner at week 11 of a 16-week outdoor track build presents with a four-week plateau on her 5k pace, muscle soreness extending into day three after her hard sessions, a 24-hour recall log showing 1,800 kcal against an estimated 2,400 kcal need, a cycle gap at eight weeks with a previous luteal-phase complaint, and a 25-hydroxyvitamin D of 42 ng/mL drawn at her annual physical six weeks earlier. The storage-form vitamin D reads replete against both the Endocrine Society and the Institute of Medicine reference brackets. The team physician reads the panel as vitamin D sufficient. The sports RD reads the panel differently. The persistent symptom complex, the cycle disruption, and the low-energy-availability pattern on the log flag a vitamin D endocrine axis the storage-form marker alone does not read. The paired draw — 25-hydroxyvitamin D plus 1,25-dihydroxyvitamin D, the active hormonal form — is the one that carries the differential forward.
The Biology — Storage Form vs Active Hormone
Vitamin D travels through the body in three sequential pools the clinical laboratory can measure separately. Cutaneous synthesis and oral intake deliver cholecalciferol (D3) and ergocalciferol (D2). The liver 25-hydroxylates both into 25-hydroxyvitamin D, which circulates bound to vitamin D binding protein with a plasma half-life of two to three weeks. The kidney 1-alpha-hydroxylates 25-OH-D into 1,25-dihydroxyvitamin D — calcitriol, the hormonally active ligand that binds the vitamin D receptor — with a plasma half-life of four to six hours.
The 25-OH-D pool is the storage marker. It reads the integrated two-to-three-week vitamin D exposure and it does not fluctuate meaningfully across the day, across a training session, or across a meal. It is the right marker to read vitamin D sufficiency against the long-term intake-and-sunlight trajectory. It is the wrong marker to read the endocrine axis against a calcium-demand signal.
The 1,25-DH-D pool is the hormonal marker. It is tightly regulated by parathyroid hormone, by serum calcium, by serum phosphate, and by fibroblast growth factor 23 (FGF-23). A rising calcium demand — luteal-phase bone turnover, high-intensity weight-bearing training, lactation, growth, or a repletion response to a dietary calcium restriction — up-regulates the renal 1-alpha-hydroxylase, converts more of the storage pool into the active form, and pushes the 1,25-DH-D value toward the top of the reference bracket. The 25-OH-D pool reads unchanged across this up-regulation because the storage marker does not measure the activation step. A paired draw reads the activation; a single 25-OH-D does not.
The Reference Brackets
25-hydroxyvitamin D reference bracket (serum, ng/mL — multiply by 2.5 for nmol/L):
- Deficient: below 20 ng/mL
- Insufficient: 20–29 ng/mL
- Sufficient: 30–50 ng/mL (Endocrine Society target for musculoskeletal and bone-health outcomes)
- Potentially excessive: above 80 ng/mL
- Toxic: sustained above 100 ng/mL
1,25-dihydroxyvitamin D reference bracket (serum, pg/mL — laboratory-dependent; verify against the issuing lab):
- Adult reference bracket: 18–72 pg/mL
- Upper-third of bracket (up-regulated activation): above 54 pg/mL
- Middle-third of bracket (balanced activation): 36–54 pg/mL
- Bottom-third of bracket (down-regulated or substrate-limited): below 36 pg/mL
The sports RD reads both numbers against the bracket on the laboratory report and records the paired percent-of-bracket-midpoint in the Objective section alongside the raw values.
The Four Paired-Draw Patterns
Pattern 1 — Replete storage, mid-bracket active. 25-OH-D at 35–50 ng/mL, 1,25-DH-D at 36–54 pg/mL. The storage pool is adequate, the activation step is proceeding at the expected rate, the endocrine axis reads as balanced. This is the picture of a well-fueled, calcium-replete athlete.
Pattern 2 — Replete storage, up-regulated active. 25-OH-D at 30–50 ng/mL, 1,25-DH-D above 54 pg/mL. The storage pool reads sufficient, but the active-form assay reads an up-regulation driven by a calcium-demand signal the storage marker does not see. The differential narrows to low dietary calcium intake, luteal-phase bone turnover in a female athlete, a high-intensity weight-bearing training load, a secondary-hyperparathyroidism pattern, or granulomatous 1-alpha-hydroxylase activation (sarcoidosis, lymphoma, chronic granulomatous infection). The paired PTH, ionized calcium, and — when the granulomatous differential is on the list — a paired ACE level separate the branches.
Pattern 3 — Low storage, mid-bracket or high active. 25-OH-D below 30 ng/mL, 1,25-DH-D inside or above the middle third. The storage pool is running low and the body is converting the remaining substrate at an accelerated rate to maintain the calcium-regulatory pool. This is the subclinical vitamin D deficiency the 25-OH-D alone does not flag at the clinical-insufficiency boundary. The repletion dose is written against the 25-OH-D value and the 1,25-DH-D is the trajectory marker on the follow-on redraw.
Pattern 4 — Any storage, suppressed active. 25-OH-D at any value, 1,25-DH-D below 30 pg/mL. The activation step is inhibited. The differential includes renal 1-alpha-hydroxylase dysfunction, elevated FGF-23 drive (phosphate-wasting disorder, tumor-induced osteomalacia, chronic hypophosphatemia), chronic kidney disease, hypoparathyroidism, and medication effects (ketoconazole, calcineurin inhibitors). The sports RD flags the pattern for a sports-endocrinology or nephrology referral, not a dietary intervention.
The Four Presentations That Earn the Paired Draw
The sports RD does not pair 1,25-DH-D with every annual 25-OH-D redraw. The paired draw earns its place on an ordered panel only when one of four presentation patterns surfaces at intake or on the wearable-and-training-log review.
Presentation 1 — Low energy availability pattern with menstrual disruption. A female athlete with an estimated energy availability below 30 kcal per kilogram fat-free mass per day, a self-reported oligomenorrhea or secondary amenorrhea, and a 25-OH-D that reads replete. The paired draw reads the vitamin D endocrine axis against the known RED-S physiology — luteal-phase bone turnover is the up-regulation signal, and an up-regulated 1,25-DH-D on a replete 25-OH-D reads the bone-health-at-risk signal the storage marker alone misses.
Presentation 2 — Stress-fracture history on a replete 25-OH-D. An athlete with a current or recent (within twelve months) stress injury on a 25-OH-D at 30 ng/mL or higher. The paired draw reads the activation step against the bone-remodeling demand. An up-regulated 1,25-DH-D paired with a lower-bracket ionized calcium and an upper-bracket intact PTH reads the secondary-hyperparathyroidism-of-under-nutrition pattern that drives recurrent stress injury in the under-fueled athlete.
Presentation 3 — Persistent muscle fatigue, soreness, or weakness on replete storage. An athlete with a four-week-plus performance plateau, a Delayed-Onset-Muscle-Soreness pattern extending beyond 48 hours, or a functional-strength regression on a 25-OH-D at 30 ng/mL or higher. The paired draw reads the 1-alpha-hydroxylase step and the paired calcium, phosphate, and magnesium against the neuromuscular-fatigue differential. Pattern 4 in this presentation reads the FGF-23-driven suppression that contributes to muscle weakness in the subclinical hypophosphatemia setting.
Presentation 4 — Masters athlete with unexplained bone-density drift. A masters athlete (over 40) with a DXA T-score drift of 0.3 or more against the prior scan on a 25-OH-D that reads replete. The paired draw reads the age-related changes in the activation step. The age-related secondary-hyperparathyroidism pattern — a chronically up-regulated 1,25-DH-D paired with an upper-bracket PTH and a lower-bracket calcium — is the pattern an annual 25-OH-D alone does not surface.
Draw Timing, Specimen Handling, and the Paired Panel
Both 25-OH-D and 1,25-DH-D are drawn as serum on a standard red-top or serum-separator tube. No fasting is required. No timed-draw protocol is required for the 25-OH-D because the two-to-three-week half-life makes the storage pool stable across the day. The 1,25-DH-D is more diurnally variable than the 25-OH-D but less variable than the hormones that regulate it, and a morning draw between 7 and 9 a.m. local — coordinated with the paired panel below — is the practical compromise.
The paired panel the sports RD orders with the 1,25-DH-D: morning intact PTH, total serum calcium, ionized calcium, phosphate, magnesium, FGF-23 if the suppressed-active pattern is suspected, albumin (for the corrected-calcium calculation), creatinine and eGFR for the renal-function read, and alkaline phosphatase. The paired panel reads the calcium-phosphate-PTH-FGF-23 axis against the vitamin D endocrine axis in one draw.
Coordinate the draw with the training calendar. Schedule it on the first morning of a rest or light-session day, not immediately following a hard session or a competition weekend. PTH responds acutely to training-load stress and the paired-panel interpretation is cleaner against a 24-hour recovery window.
The 1,25-DH-D assay itself carries a methodological footnote the sports RD records in the Objective section: the LC-MS/MS and radioimmunoassay methods can produce clinically meaningful differences at the top and bottom of the reference bracket, so the follow-on redraw is ordered from the same laboratory using the same assay to keep the trajectory interpretable.
The SOAP Structure
Subjective. Document the presenting complaint (plateau, fatigue, cycle disruption, stress injury, bone-density drift), the training-load trajectory across the preceding mesocycle, the dietary-intake trajectory with an explicit calcium-intake estimate in milligrams per day, any wearable-data signals, any cycle-tracking data, any prior stress-injury history, any family history of osteoporosis or osteomalacia, and any concurrent medications (glucocorticoids, anticonvulsants, antifungals, calcineurin inhibitors).
Objective. Record the paired 25-OH-D and 1,25-DH-D values plus the reference brackets plus the percent-of-bracket-midpoint. Record the paired intact PTH, total and ionized calcium, phosphate, magnesium, albumin, creatinine, eGFR, and alkaline phosphatase. Record the pattern classification (1, 2, 3, or 4) from the paired-draw interpretation. Record the dietary calcium estimate against the age- and sex-stratified RDA. Record the DXA or bone-turnover-marker trajectory if available. Record the laboratory assay methodology (LC-MS/MS vs immunoassay) for the 1,25-DH-D so the follow-on redraw matches.
Assessment. Read the paired pattern against the clinical differential. Document the ruled-out differentials with reference to the paired markers that ruled them out (secondary hyperparathyroidism ruled in or out by paired PTH; granulomatous activation ruled in or out by paired ACE level and the chest-imaging decision; FGF-23-driven suppression ruled in or out by paired FGF-23 and phosphate; medication effect ruled in or out by the medication reconciliation).
Plan. Write the dietary intervention: a calcium-intake target against the RDA floor, a vitamin D repletion or maintenance dose against the 25-OH-D trajectory, a dietary phosphate audit against the 1,25-DH-D pattern, and an energy-availability intervention against the paired RED-S picture. Write the training-load coordination with the strength-and-conditioning coach where the bone-health pattern earns a reduction in high-impact loading. Write the sports-endocrinology or nephrology referral trigger (Pattern 2 up-regulation in a stress-injury history, Pattern 4 suppressed active, any paired PTH outside the reference bracket paired with an abnormal calcium, any 1,25-DH-D above 72 pg/mL with hypercalcemia). Schedule the follow-on redraw at eight to twelve weeks post-intervention.
Referral Pathways and Follow-On Redraw Cadence
A Pattern 2 up-regulation with a paired PTH above the upper-third of the reference bracket earns the endocrinology referral for the secondary-hyperparathyroidism workup. A Pattern 4 suppressed active with a low or normal phosphate and a preserved eGFR earns the nephrology or endocrinology referral for the FGF-23 and 1-alpha-hydroxylase workup. Any 1,25-DH-D above 72 pg/mL with concurrent hypercalcemia earns the same-day endocrinology consult for the granulomatous-activation differential. The sports RD frames the referral as "paired vitamin D endocrine axis finding with [pattern-specific] paired-panel abnormalities" and attaches the paired-panel values, the training-load trajectory, the dietary-intake log, and the symptom timeline as documentation.
The follow-on redraw cadence is eight to twelve weeks post-intervention. A responding athlete shows a 25-OH-D drift toward the top of the sufficient bracket and a 1,25-DH-D returning to the middle third of its bracket. A non-responding athlete with a persistent up-regulated active form despite a dietary calcium intervention reads for the sports-endocrinology referral regardless of the storage-form value. The redraw window is long enough to allow the storage pool to turn over meaningfully — three-to-four half-lives for a stable new value — and to allow the 1-alpha-hydroxylase set point to re-equilibrate against the corrected calcium-and-phosphate input.
Calsanova's Clinical Workflow
Calsanova's clinical intake carries the energy-availability-and-cycle-tracking capture that flags the paired-draw differential, the lab-interpretation module that reads 25-OH-D plus 1,25-DH-D against both reference brackets with the pattern classification pre-computed from the paired-panel entries, the SOAP template pre-populated against the vitamin D endocrine axis read with the dietary, training-load, and referral branches of the plan assembled from the pattern-specific template library, the assay-methodology field that carries forward to the follow-on redraw order so the trajectory stays interpretable, and the follow-on-redraw scheduler that places the eight-to-twelve-week recheck on the athlete's calendar at the moment of the intervention.
Ready to move your sports-nutrition clinical workflow into a purpose-built system? [Try Calsanova free for 30 days](/signup?role=dietitian) — no credit card, HIPAA-ready from day one, and the paired vitamin D endocrine axis workup runs cleanly against the Endocrine Society reference brackets, the four-pattern paired interpretation, the paired calcium-phosphate-PTH-FGF-23 panel, the SOAP template, and the eight-to-twelve-week follow-on redraw scheduler that tracks the recovery trajectory against the dietary, training-load, and endocrinology-referral branches of the plan.
Ready to modernize your practice?
Calsanova gives dietitians AI-powered meal planning, food recognition, video consultations, and HIPAA-compliant infrastructure.
Start your free trialGet more like this.
Evidence-based writing on nutrition, performance, and the research behind what actually works. No spam, no daily emails — just the good stuff.
Written by Nelson Marques, MS, RD, LD — a registered dietitian and performance nutrition specialist. Founder of Calsanova. More about Nelson
More from the Classroom
Bone Turnover Markers (Serum CTX and P1NP) in the Sports RD Workup: Why the Paired Resorption-and-Formation Panel Catches the Active Bone-Loss Signal DXA Reads Six Months Late, the Draw-Protocol Discipline That Controls the Diurnal and Meal-State Variance the Standard Reference Ranges Ignore, and the SOAP Assessment Structure That Documents the Coupled-Uncoupled Read So the Referral Starts at the Right Question
A 22-year-old female collegiate cross-country runner presents to the sports RD on referral with two consecutive tibial stress reactions on the same tibia across the last twelve months, a DXA from three months ago flagged 'within reference for age,' a computed energy availability of 33 kcal/kg FFM/day, a serum 25-hydroxyvitamin D of 38 ng/mL, and a regular menstrual cycle. The referring note reads 'rule out low energy availability and calcium/vitamin D intake.' The DXA is not wrong — it is the wrong tool for the question the presenting picture is asking. DXA integrates bone-mineral-density history across many months to years of prior turnover; it cannot see what the athlete's remodeling coupling is doing this week or this training block. Two consecutive stress reactions on the same tibia in twelve months is the signal that the resorption-formation coupling has shifted toward net resorption, and the paired serum C-terminal telopeptide (CTX) and procollagen type 1 N-terminal propeptide (P1NP) panel is the workup that catches it at the intervention window that still reverses cleanly. This is the bone-turnover-marker interpretation guide for the sports RD: what CTX and P1NP actually measure and why they read a real-time signal DXA cannot, the fasted-morning-no-recent-training-same-lab-same-assay draw-protocol discipline that controls the diurnal and meal-state variance the reference ranges quietly absorb, the four intake presentations that should trigger the paired panel regardless of the DXA read, the coupled-versus-uncoupled interpretation framework that separates the healthy loaded skeleton from the LEA-driven or hypogonadism-driven net-resorption pattern, the SOAP assessment structure that documents the coupling read so the endocrinology or sports-medicine referral starts at the correct question, and the paired energy-availability-plus-mechanical-loading intervention loop the sports RD holds across the 12-to-16-week reassessment cadence.
September 3, 2026
IGF-1 and IGFBP-3 in the Athlete Clinical Workup: Why the Spot IGF-1 Alone Misses the Hepatic GH-Resistance Signature of Low Energy Availability, the Computed Molar Ratio That Reads the Ternary-Complex Biology, the Four Paired-Draw Patterns That Classify the GH-IGF-1 Axis, and the SOAP Structure That Carries the Finding Into the Energy-Availability, Training-Load, and Sports-Endocrinology-Referral Branches of the Plan
A 20-year-old female NCAA Division I distance swimmer presents at week 14 of a 22-week championship build with a six-week plateau on her 200-meter freestyle splits, a 1.2-kilogram loss of DXA-measured fat-free mass, a luteal-phase deficiency on a four-month basal-body-temperature chart, a 24-hour recall log at 2,100 kcal against an estimated 2,750-kcal need, and a team-physician-ordered IGF-1 that returned 215 ng/mL. The laboratory report flags the value as within the age-decade reference bracket and the ordering physician's chart note reads IGF-1 normal, no further endocrine workup indicated. The spot IGF-1 reads the panel as reassuring. The integrated growth-hormone-IGF-axis signal that is actually driving the plateau is not readable from the IGF-1 alone. The marker that reads the hepatic GH-resistance signature against the dominant binding-protein pool, insulin-like growth factor binding protein 3 (IGFBP-3), and the computed IGF-1/IGFBP-3 molar ratio that reads against the ternary-complex biology are the two reads the sports RD has to add to the next panel. This is the paired IGF-1 plus IGFBP-3 interpretation guide for the sports RD: the GH-receptor-to-JAK2-STAT5 biology that drives the dissociated storage-versus-synthesis signal, the age-decade reference brackets, the four paired-draw patterns that classify the GH-IGF-1 axis, the four athlete-population presentations that earn the ordered paired draw, the paired-panel assembly against the free-T3-and-gonadal-axis RED-S differential, the SOAP structure that carries the finding into the energy-availability, training-load, and sports-endocrinology-referral branches of the plan, and the eight-to-twelve-week follow-on redraw cadence that tracks the recovery trajectory against the pattern-specific intervention.
November 19, 2026
Alkaline Phosphatase (ALP) Isoenzyme Interpretation in the Athlete Clinical Workup: Why a Mildly Elevated Total ALP on a Routine Panel Is a Bone-Remodeling Signal Until the Paired GGT and the Bone-Specific ALP Say Otherwise, the Loading-Phase and Growth-Plate Context That Explains the Lift, and the SOAP Structure That Carries the Finding Into the Bone-Health, Training-Load, and Hepatology-Referral Branches of the Plan
A 17-year-old female high school cross-country runner arrives at the sports RD with a pre-season physical panel returning a total alkaline phosphatase of 142 U/L against a laboratory reference bracket upper bound of 115 U/L. The pediatric-sports-medicine ordering physician flagged the reading as "mildly elevated ALP, repeat in six weeks, consider hepatology referral if persistent." The athlete, her coach, and the parents arrived at the intake session asking whether the training plan, the oral contraceptive pill she started three months prior, or an occult hepatobiliary disease was the driver of the lift. The read is almost certainly a bone-remodeling signal. The adolescent growth plate is open, the peak-height-velocity window has not yet closed in a sizable fraction of 17-year-old female runners, and bone-specific ALP (BSAP) — the osteoblast-derived isoenzyme — contributes between 40 and 70 percent of total serum ALP in the adolescent population against an adult reference of approximately 40 to 50 percent. The paired marker that reads the hepatobiliary signal against the bone-remodeling signal is the gamma-glutamyl transferase (GGT), a hepatobiliary-exclusive enzyme that does not rise with bone-driven ALP elevations. This is the ALP isoenzyme interpretation guide for the sports RD: the four-isoenzyme biology (bone, liver, intestinal, placental) that drives the total-ALP reading, the paired GGT read that separates the hepatic from the bone signal without ordering a direct isoenzyme fractionation, the bone-specific ALP (BSAP) direct-measurement option when the GGT read is ambiguous, the age-and-training-phase context that explains the loading-phase and growth-spurt elevation patterns, the four intake presentations that earn the ordered workup rather than the reflexive hepatology referral, and the SOAP structure that carries the finding into the bone-health, training-load, and hepatology-referral branches of the plan.
November 5, 2026